Conference Description
The Cannabinoid Function in the CNS GRS provides a unique forum for young doctoral and post-doctoral researchers to present their work, discuss new methods, cutting edge ideas, and pre-published data, as well as to build collaborative relationships with their peers. Experienced mentors and trainee moderators will facilitate active participation in scientific discussion to allow all attendees to be engaged participants rather than spectators.
The 2025 Cannabinoid Gordon Research Seminar (GRS) is committed to being an exceptional and inclusive conference, dedicated to exploring novel scientific questions in the cannabinoid field, Featuring keynote speaker Dr. Staci Gruber. Our focus on cutting-edge research spans both endogenous and plant cannabinoids, fostering an environment where graduate students and post-doctoral associates are empowered to assertively showcase their work. Emphasizing mentorship, our conference offers a platform for emerging talents to connect, learn, and establish meaningful collaborations. In our pursuit of inclusivity and diversity, the 2025 Cannabinoid GRS works to create an environment that celebrates and respects individuals from all backgrounds. We understand the importance of addressing barriers and challenges to inclusivity and are dedicated to implementing concrete actions to overcome them. From diverse speaker panels to accessibility accommodations, we strive to ensure that every participant feels valued and included. This event will bring together cannabinoid researchers at both pre-clinical and clinical levels. From bench to bedside, the Cannabinoid GRS provides a translational environment, exploring the intricate mechanisms underlying cannabinoid function and showcasing the clinical applications of these compounds. Join us for an immersive experience that bridges the gap between groundbreaking research and practical applications in the cannabinoid field.
An outline of the program components for this GRS is displayed below. The seminar chair is currently developing their detailed program schedule, which will include the speakers they select from submitted abstracts, in addition to any additional components outlined below. The detailed program will be available by June 17, 2025. Please check back for updates.
Speakers
- To Be Selected from Submitted Abstracts
Discussion Leaders
- To Be Selected from Submitted Abstracts
Mentorship Component
- "Charting Pathways in Cannabinoids: Navigating the Clinical Practice and Research Across Industry, Medicine, and Academia"
